Kinfo
Aeon Biopharma Inc. logo

Aeon Biopharma Inc.

AEONNYSEHealthcare·US · USD
$0.32
-0.16 (-33.31%)
Prices as of July 13, 2026 · market closed

Price

Key statistics

Valuation
Market cap8.47M USD
Enterprise value9.09M USD
Trailing P/E0.33
Forward P/E-0.70
PEG ratio-0.00
Price / sales0.00
Price / book-0.78
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-101.93%
Return on equity71.28%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA-18.21M USD
Net income-60.11M USD
Diluted EPS-$6.52
Rev. growth (YoY)0.00%
Balance sheet
Total cash6.24M USD
Total debt2.63M USD
Debt / equity-0.16
Current ratio0.99
Book value / share-$0.66
Cash flow (TTM)
Operating cash flow-12.04M USD
Levered free cash flow-6.37M USD
Shares & price
Shares outstanding25.30M
Float9.93M
Held by institutions5.45%
Beta0.61
50-day MA$0.76
200-day MA$0.95
52-week high$1.45
52-week low$0.30
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-05-14-0.44-0.25+43.18%2026-03-30-0.20-3.72−1,760.00%2026-03-20-0.18-0.15+16.67%2026-02-020.850.87+2.35%2026-01-170.380.34−10.53%
About Aeon Biopharma Inc.

Aeon Biopharma Inc. is a biopharmaceutical company focusing on the development and commercialization of therapeutic treatments across a broad spectrum of medical conditions. Its primary mission is to leverage innovative biotechnological advancements to improve patient outcomes, particularly in the realm of neurology and other chronic and debilitating disorders. Aeon Biopharma places significant emphasis on research and development, seeking to introduce novel therapies that can transform standard care practices. Operating within the dynamic pharmaceutical sector, the company has an impact on healthcare providers, regulatory bodies, and patients by advancing medical solutions that could potentially alleviate conditions previously thought to be untreatable. As an integral part of the biotechnology industry, Aeon Biopharma Inc. contributes to the broader medical innovation landscape, aiming to meet the growing demands for effective medical interventions by employing cutting-edge research methodologies and strategic partnerships.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Robert Bancroft
Employees
8
Headquarters
Irvine, CA, United States

Frequently asked questions about Aeon Biopharma Inc.